1 | 4LAR |
Single chain antibody fragment scFv6H4 | Mus musculus |
- |
(2S)-1-phenylpropan-2-amine |
1WE |
|
0.55 |
SHOW |
2 | 3GM0 |
Anti-methamphetamine single chain Fv | Mus musculus |
- |
(2S)-1-(1,3-benzodioxol-5-yl)-N-methylpropan-2-amine |
B41 |
|
0.53 |
SHOW |
3 | 3MEG |
Reverse transcriptase | Human immunodeficiency virus type 1 group M subtype B |
P04585 (POL_HV1H2) |
4-{[4-({4-[(E)-2-cyanoethenyl]-2,6-dimethylphenyl}amino)pyrimidin-2-yl]amino}benzonitrile |
T27 |
|
0.51 |
SHOW |
4 | 1S6Q |
Gag-Pol polyprotein | Human immunodeficiency virus type 1 group M subtype B |
P03366 (POL_HV1B1) |
4-[4-(2,4,6-TRIMETHYL-PHENYLAMINO)-PYRIMIDIN-2-YLAMINO]-BENZONITRILE |
TPB |
|
0.5 |
SHOW |
5 | 1UWG |
Antibody 14D9 | Mus musculus / Homo sapiens |
- |
1-(4-{[(2-HYDROXYETHYL)AMINO]CARBONYL}BENZYL)-1-METHYLPIPERIDINIUM |
KHA |
|
0.5 |
SHOW |
6 | 6UL5 |
Gag-Pol polyprotein | Human immunodeficiency virus type 1 group M subtype B |
P03366 (POL_HV1B1) |
4-[(4-{4-[(E)-2-cyanoethenyl]-2,6-dimethylphenoxy}thieno[3,2-d]pyrimidin-2-yl)amino]-2-fluorobenzonitrile |
QAG |
|
0.47 |
SHOW |
7 | 4LAS |
Single chain antibody fragment scFv6H4 | Mus musculus |
- |
4-[(2S)-2-(methylamino)propyl]phenol |
1WF |
|
0.47 |
SHOW |
8 | 6DTW |
Gag-Pol polyprotein | Human immunodeficiency virus type 1 group M subtype B |
P03366 (POL_HV1B1) |
8-{2-[2-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)ethoxy]-4-fluorophenoxy}-6-fluoroindolizine-2-carbonitrile |
H9Y |
|
0.47 |
SHOW |
9 | 6PUF |
Major histocompatibility complex class I-related gene protein | Homo sapiens |
Q95460 (HMR1_HUMAN) |
1-deoxy-1-({2,6-dioxo-5-[(E)-(2-oxopropylidene)amino]-1,2,3,6-tetrahydropyrimidin-4-yl}amino)-D-ribitol |
2LJ |
|
0.46 |
SHOW |
10 | 1IKX |
Gag-Pol polyprotein | Human immunodeficiency virus type 1 group M subtype B |
P03366 (POL_HV1B1) |
6-CHLORO-2-(1-FURO[2,3-C]PYRIDIN-5-YL-ETHYLSULFANYL)-PYRIMIDIN-4-YLAMINE |
PNU |
|
0.46 |
SHOW |
11 | 6X4D |
Gag-Pol polyprotein | Human immunodeficiency virus type 1 group M subtype B |
P03366 (POL_HV1B1) |
5-(cyclopropylmethyl)-7-{2-[2-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)ethoxy]phenoxy}-8-methylnaphthalene-2-carbonitrile |
UO4 |
|
0.46 |
SHOW |
12 | 6X4B |
Gag-Pol polyprotein | Human immunodeficiency virus type 1 group M subtype B |
P03366 (POL_HV1B1) |
7-{2-[2-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)ethoxy]phenoxy}-5-fluoro-8-methylnaphthalene-2-carbonitrile |
UMY |
|
0.45 |
SHOW |
13 | 4KV8 |
Reverse transcriptase | Human immunodeficiency virus type 1 group M subtype B |
P04585 (POL_HV1H2) |
11-ethyl-5-methyl-8-[2-(1-oxidanylquinolin-4-yl)oxyethyl]dipyrido[3,2-[1,4]diazepin-6-one |
1WT |
|
0.45 |
SHOW |
14 | 4K3H |
Immunoglobulin lambda variable domain L5(L89S) | Homo sapiens |
- |
4-{bis[4-(dimethylamino)phenyl]methyl}phenol |
1OM |
|
0.45 |
SHOW |
15 | 1S1V |
Reverse transcriptase | Human immunodeficiency virus type 1 group M subtype B |
P04585 (POL_HV1H2) |
6-BENZYL-1-BENZYLOXYMETHYL-5-ISOPROPYL URACIL |
TNK |
|
0.45 |
SHOW |
16 | 2Y57 |
Soluble acetylcholine receptor | Aplysia californica |
Q8WSF8 (Q8WSF8_APLCA) |
[(1R,5S)-8-PHENETHYL-8-AZABICYCLO[3.2.1]OCTAN-3-YL] BENZOATE |
V37 |
|
0.45 |
SHOW |
17 | 2Y56 |
Soluble acetylcholine receptor | Aplysia californica |
Q8WSF8 (Q8WSF8_APLCA) |
[(1S,5R)-8-[(2R)-2-HYDROXY-2-PHENYL-ETHYL]-8-AZABICYCLO[3.2.1]OCTAN-3-YL] BENZOATE |
V11 |
|
0.44 |
SHOW |
18 | 6DTX |
Gag-Pol polyprotein | Human immunodeficiency virus type 1 group M subtype B |
P03366 (POL_HV1B1) |
8-{2-[2-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)ethoxy]-4-fluorophenoxy}-6-fluoroindolizine-2-carbonitrile |
H9Y |
|
0.44 |
SHOW |
19 | 5FJV |
Neuronal acetylcholine receptor subunit alpha-2 | Homo sapiens |
Q15822 (ACHA2_HUMAN) |
EPIBATIDINE |
EPJ |
|
0.44 |
SHOW |
20 | 6X47 |
Gag-Pol polyprotein | Human immunodeficiency virus type 1 group M subtype B |
P03366 (POL_HV1B1) |
7-(2-(2-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)ethoxy)phenoxy)-2-naphthonitrile |
7AX |
|
0.43 |
SHOW |
21 | 6QQO |
Soluble acetylcholine receptor | Aplysia californica |
Q8WSF8 (Q8WSF8_APLCA) |
6-[5-[(1~{R},2~{R},4~{S})-7-azabicyclo[2.2.1]heptan-2-yl]-2-fluoranyl-pyridin-3-yl]pyridine-3-carboxamide |
JC8 |
|
0.43 |
SHOW |
22 | 6QKK |
Soluble acetylcholine receptor | Aplysia californica |
Q8WSF8 (Q8WSF8_APLCA) |
4-[5-[(1~{R},2~{R},4~{S})-7-azabicyclo[2.2.1]heptan-2-yl]-2-fluoranyl-pyridin-3-yl]benzamide |
H92 |
|
0.43 |
SHOW |
23 | 2YMD |
Soluble acetylcholine receptor | Aplysia californica |
Q8WSF8 (Q8WSF8_APLCA) |
SEROTONIN |
SRO |
|
0.43 |
SHOW |
24 | 1S9E |
Gag-Pol polyprotein | Human immunodeficiency virus type 1 group M subtype B |
P03366 (POL_HV1B1) |
4-[4-AMINO-6-(2,6-DICHLORO-PHENOXY)-[1,3,5]TRIAZIN-2-YLAMINO]-BENZONITRILE |
ADB |
|
0.43 |
SHOW |
25 | 6NW4 |
Indole-3-glycerol phosphate synthase | Saccharolobus solfataricus |
Q06121 (TRPC_SACS2) |
6-NITROBENZOTRIAZOLE |
6NT |
|
0.42 |
SHOW |
26 | 6NP0 |
5-hydroxytryptamine receptor 3A | Mus musculus |
P23979 (5HT3A_MOUSE) |
1-methyl-N-[(1R,5S)-9-methyl-9-azabicyclo[3.3.1]nonan-3-yl]indazole-3-carboxamide |
CWB |
|
0.42 |
SHOW |
27 | 4KYS |
Thiamine pyridinylase I | Clostridium botulinum A str. ATCC 19397 |
- |
3-(4-AMINO-2-METHYL-PYRIMIDIN-5-YLMETHYL)-5-(2-HYDROXY-ETHYL)-4-METHYL-THIAZOL-3-IUM |
VIB |
|
0.42 |
SHOW |
28 | 5PMO |
Lysine-specific demethylase 4D | Homo sapiens |
Q6B0I6 (KDM4D_HUMAN) |
N-OXALYLGLYCINE |
OGA |
|
0.42 |
SHOW |
29 | 3WTO |
Acetylcholine-binding protein | Lymnaea stagnalis |
P58154 (ACHP_LYMST) |
(2Z)-1-[(6-chloropyridin-3-yl)methyl]imidazolidin-2-imine |
N2Y |
|
0.42 |
SHOW |
30 | 4ALX |
Acetylcholine-binding protein | Lymnaea stagnalis |
P58154 (ACHP_LYMST) |
(4bS,6S)-6-methoxy-1,4,6,7,9,10,12,13-octahydro-3H,5H-pyrano[4',3':3,4]pyrido[2,1-i]indol-3-one |
IZN |
|
0.42 |
SHOW |
31 | 6X4C |
Gag-Pol polyprotein | Human immunodeficiency virus type 1 group M subtype B |
P03366 (POL_HV1B1) |
7-{2-[2-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)ethoxy]-4-fluorophenoxy}-5,8-dimethylnaphthalene-2-carbonitrile |
UNS |
|
0.42 |
SHOW |
32 | 5PMP |
Lysine-specific demethylase 4D | Homo sapiens |
Q6B0I6 (KDM4D_HUMAN) |
N-OXALYLGLYCINE |
OGA |
|
0.42 |
SHOW |
33 | 3WTN |
Acetylcholine-binding protein | Lymnaea stagnalis |
P58154 (ACHP_LYMST) |
(2Z)-1-[(6-chloropyridin-3-yl)methyl]imidazolidin-2-imine |
N2Y |
|
0.41 |
SHOW |
34 | 5PMH |
Lysine-specific demethylase 4D | Homo sapiens |
Q6B0I6 (KDM4D_HUMAN) |
N-OXALYLGLYCINE |
OGA |
|
0.41 |
SHOW |
35 | 5PMV |
Lysine-specific demethylase 4D | Homo sapiens |
Q6B0I6 (KDM4D_HUMAN) |
N-OXALYLGLYCINE |
OGA |
|
0.41 |
SHOW |
36 | 5PMF |
Lysine-specific demethylase 4D | Homo sapiens |
Q6B0I6 (KDM4D_HUMAN) |
N-OXALYLGLYCINE |
OGA |
|
0.41 |
SHOW |
37 | 5PMW |
Lysine-specific demethylase 4D | Homo sapiens |
Q6B0I6 (KDM4D_HUMAN) |
N-OXALYLGLYCINE |
OGA |
|
0.41 |
SHOW |
38 | 5PMX |
Lysine-specific demethylase 4D | Homo sapiens |
Q6B0I6 (KDM4D_HUMAN) |
N-OXALYLGLYCINE |
OGA |
|
0.41 |
SHOW |
39 | 2ZJU |
Acetylcholine-binding protein | Lymnaea stagnalis |
P58154 (ACHP_LYMST) |
(2E)-1-[(6-chloropyridin-3-yl)methyl]-N-nitroimidazolidin-2-imine |
IM4 |
|
0.41 |
SHOW |
40 | 3ZDH |
Acetylcholine-binding protein | Lymnaea stagnalis |
P58154 (ACHP_LYMST) |
(2R)-N,N-dimethyl-4-(1-methylimidazol-2-yl)oxy-butan-2-amine |
XRS |
|
0.41 |
SHOW |
41 | 6Y1Z |
5-hydroxytryptamine receptor 3A | Mus musculus |
P23979 (5HT3A_MOUSE) |
(3~{a}~{S})-2-[(3~{S})-1-azabicyclo[2.2.2]octan-3-yl]-3~{a},4,5,6-tetrahydro-3~{H}-benzo[de]isoquinolin-1-one |
O7B |
|
0.41 |
SHOW |
42 | 3R9F |
MccE protein | Escherichia coli |
Q47510 (Q47510_ECOLX) |
O5'-(L-GLUTAMYL-SULFAMOYL)-ADENOSINE |
GSU |
|
0.41 |
SHOW |
43 | 6QVO |
7,8-dihydro-8-oxoguanine triphosphatase | Homo sapiens |
P36639 (8ODP_HUMAN) |
N6-METHYL-DEOXY-ADENOSINE-5'-MONOPHOSPHATE |
6MA |
|
0.41 |
SHOW |
44 | 1NC4 |
Monoclonal Antibody 2D12.5 Fab | Mus musculus |
- |
(S)-2-(4-NITROBENZYL)-1,4,7,10-TETRAAZACYCLODODECANE-N,N',N'',N'''-TETRAACETATE |
DOF |
|
0.41 |
SHOW |
45 | 2ZJV |
Acetylcholine-binding protein | Lymnaea stagnalis |
P58154 (ACHP_LYMST) |
1-[(2-chloro-1,3-thiazol-5-yl)methyl]-3-methyl-2-nitroguanidine |
CT4 |
|
0.41 |
SHOW |